Spinning Clinical Trials

Reports from clinical trials for breast cancer drugs are often rife with bias and spin, according to a study published this week (January 9) in Annals of Oncology.

Researchers from the University of Toronto analyzed the publications from 164 randomized Phase III clinical trials and found that a third were reported positively despite not meeting the primary objective, by emphasizing other, less important outcomes.

Posted by Joseph Hany

Spinning Clinical Trials

No Comments

Leave a Comment